The EchoGo Heart Failure tool was created by Ultromics, a spinoff of the University of Oxford in the U.K. in collaboration with Mayo Clinic. It uses AI to detect heart failure with reduced ejection fraction, or HFpEF, from a single electrocardiogram image, aiming to expedite care.
“HFpEF currently is associated with high rates of hospitalization and mortality,” Patricia Pellikka, MD, vice chair of cardiovascular medicine at Mayo Clinic, said in a Dec. 6 Ultromics news release. “By facilitating early diagnosis and treatment, we can improve the lives of many.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.